A research team from Kumamoto University has made a groundbreaking discovery that reveals how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body, potentially laying the foundation for new therapeutic approaches. Their findings, published on May 13, 2025, in Nature Microbiology, identify a previously unknown genetic “silencer” element that keeps the virus in a dormant, undetectable state.
HTLV-1 is a cancer-causing retrovirus known to lead to adult T-cell…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply